Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Best Practices For Successful Filter Integrity Testing Using Water Intrusion Test (WIT) Method
Monica Cardona and Ian Johnson Pall Life Sciences
Choice of Upstream Bioreactor Technologies for Industrial Scale Viral Manufacturing (White Paper USD3244)
Pall Corporation
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Current Status of Analytical Techniques for Characterization of Protein Stability
Dr. Sanket Patke, Research Investigator at Bristol-Myers Squibb with Dr. Joshua Stillahn and Dr Manning
View All Featured ArticlesHeadline News
Abbott’s Cologuard screening linked to fewer colorectal cancer cases and lower risk of death in new real world data
Regeneron’s Pasatru shows no new bone lesions in adult FOP patients between weeks 56 and 84 of OPTIMA
Teva’s Weltruza becomes first once monthly subcutaneous olanzapine injection to win FDA approval for adults with schizophrenia
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Next Generation Manufacturing at Biogen – PAT as an Enabler for Enhanced Process
Presented by Oliver Steinhof, PAT Scientist at Biogen and Martin Gadsby, Owner, Optimal Industrial Automation Ltd
06th November 2020
Demonstrate how machine learning tools can aid development of formulation, analysis and manufacturing of pharmaceutical drug products
Presented by Erik Skibsted, Principal Scientist PhD, Novo Nordisk Denmark and Rolf Taaning, Development Specialist PhD, Novo Nordisk Denmark
08th March 2021
Subvisible Particle Identification & Characterisation by Multi-Technique Methods
Presented by Dr. Jonas Hoeg Thygesen, Novo Nordisk Pharmatech. Followed by Colin Merrifield, ProteinSimple
23rd February 2017
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Best Practices for Achieving Virus Safety
Strategy Emerging Markets for Risk Mitigation
Lifetime study for JSR Amsphere A3 – protein A resin
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
